The Sustainable Development Goals highlight the importance of good governance for realizing development goals, including universal health coverage. Governance concerns include the effective prevention and management of conflicts of interest that may compromise the integrity of decision-making in the public pharmaceutical sector. This online course has been developed to support countries with practical guidance on preventing and managing conflicts of interest in public pharmaceutical systems.
Photo credits: WHO / Blink media - Saiyna Bashir
Overview: In collaboration with the World Health Organization (WHO) Division of Medicines and Health Products and other partners, the USAID Medicines Technologies and Pharmaceutical Services (MTaPS) coordinated the development of the WHO approved ‘Managing conflicts of interest, a how-to guide for public pharmaceutical-sector committees in low- and middle-income countries’ manual.
The manual was developed in response to the need to improve understanding of conflict of interest (COI) in public pharmaceutical decision making and the need for guidance on preventing and managing it. The manual identifies and explains ten critical steps for strengthening COI policy, prevention, and management in public pharmaceutical decision-making committees.
The approach is practical and may be adaptable to specific contexts and elaborated on as more evidence is gathered. The manual was published on the WHO website in September 2022 and is accessible to everyone.
Course duration: Approximately 1 hour.
Certificates: A Certificate of Achievement will be available to participants who score at least 80% of the total points available in the final assessment. Participants who receive a Record of Achievement can also download an Open Badge for this course. Click here to learn how.